<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Democratic Republic of the Congo</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Democratic Republic of the Congo.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/cd.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Field Investigation of the Bundibugyo Ebola Virus Disease (BDBV) Outbreak in Ituri Province, Democratic Republic of the Congo: Challenges, Strategies, and Priority Actions for Outbreak Control—An Outbreak Investigation Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-idr18050100-0286cca8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-idr18050100-0286cca8/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames the outbreak as a major Ebola control challenge in a conflict-affected and socially complex setting. It identifies surveillance, contact tracing, laboratory capacity, IPC, clinical care, risk communication, misinformation management, and community trust as priority areas for outbreak response and preparedness.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Implementing an intra outbreak ring vaccination clinical trial for Sudan Ebola virus disease within four days of outbreak notification in Uganda.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</guid>
    <pubDate>Mon, 07 Sep 2026 00:00:00 GMT</pubDate>
    <description>The four-day turnaround provides a replicable blueprint for rapid medical countermeasure evaluation during future outbreaks in settings with heightened Ebola Virus Disease threat. The approach demonstrates that prepositioned protocols, established infrastructure, and trained personnel can dramatically compress trial activation timelines.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Regional signals preceding the 2026 Bundibugyo virus disease outbreak</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108862-d477aad3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108862-d477aad3/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to potential deficiencies in protocols for managing cases that test negative for standard pathogens.</description>
    <category>Hemorrhagic Fever</category>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo: Virology, epidemiology, continental response, and research priorities</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The document underscores urgent requirements for novel prophylactic and therapeutic development while demonstrating how transnational coordination mechanisms can address complex outbreak environments marked by infrastructure deficits and social friction.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Challenges in managing ruptured ectopic pregnancy complicated by hemorrhagic shock in an Ebola treatment unit in DR Congo: first reported case</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1848720-5309eb14/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1848720-5309eb14/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The case indicates that obstetric emergencies can arise in Ebola treatment units and that limited diagnostic, surgical, anesthetic, and referral capacity may complicate timely care. The authors conclude that such units should have capacity to diagnose and manage obstetric complications in addition to providing Ebola-related care.</description>
    <category>Ebola</category>
    <category>Malaria</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Genomic epidemiology reveals geographically structured co-circulation of AFR10 and AFR13 Vibrio cholerae lineages driving cholera outbreaks in Tanzania (2022–2024)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1099-mgen-0-001813-f29b2d9a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1099-mgen-0-001813-f29b2d9a/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>Results inform public health interventions by clarifying transmission dynamics and antimicrobial resistance patterns relevant to treatment strategies. The authors emphasize the necessity for enhanced national and cross-border genomic surveillance to manage control efforts effectively.</description>
    <category>Cholera</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Antimicrobial resistance</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76114-1-dbca88c1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76114-1-dbca88c1/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings support continued development of a pan-ebolavirus vaccine built on the I53-50 platform, which has established clinical safety, and may be relevant for populations at risk of EBOV and SUDV outbreaks.</description>
    <category>Hemorrhagic Fever</category>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Water, Sanitation and Hygiene in Ebola Preparedness and Response in South Sudan, Uganda and the Democratic Republic of the Congo: A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-19044-esipreprint-8-2026-p97-24674607/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-19044-esipreprint-8-2026-p97-24674607/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Embedding durable environmental services, practical staff education, community outreach, and regional cooperation into standard health budgets could improve future epidemic resilience.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Operationalizing One Digital Health and FAIR Data Principles for Disease Surveillance in a Low-Medium Income Country in Africa: Qualitative Study in the Democratic Republic of the Congo.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</guid>
    <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
    <description>The analysis supplies practical guidance for resource-constrained regions aiming to replace disconnected digital projects with coordinated, compatible networks that support comprehensive pathogen tracking.</description>
    <category>COVID-19</category>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Systemic barriers to achieving yellow fever vaccination coverage targets among children aged 9–23 months in the Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128995-ff19b743/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128995-ff19b743/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings identify socioeconomic, seasonal, community-mobilization, and service-delivery factors relevant to yellow fever vaccination access in the studied DRC settings. The authors indicate that outreach, community mobilization, and adaptation of services to environmental conditions may support more equitable coverage.</description>
    <category>Yellow fever</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Exploring the Potential Contribution of Climate-Informed Research to Future Ebola Preparedness in Central Africa.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-v18070782-3f9e0b9a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-v18070782-3f9e0b9a/</guid>
    <pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate>
    <description>Frequent viral outbreaks in the specified region underscore the necessity of transitioning from reactive case management to proactive risk evaluation. Integrating ecological tracking with conventional diagnostic networks may ultimately refine strategic planning for regional health authorities.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Donor dependency and pandemic readiness: insights from the 2026 Ebola Bundibugyo outbreak in the East African community.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1891266-a2986612/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1891266-a2986612/</guid>
    <pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate>
    <description>Strengthening localized financing and institutionalizing border-spanning monitoring networks could reduce systemic fragility during future pathogen emergencies.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Bundibugyo Virus Disease Outbreak and Cross-Border Response in the Democratic Republic of the Congo and Uganda, May-June 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7759-cureus-112459-e636cd4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7759-cureus-112459-e636cd4f/</guid>
    <pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate>
    <description>The discussion underscores the importance of adaptable international cooperation and localized preparedness when addressing novel hemorrhagic fever threats lacking established medical interventions.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Ebola outbreak in the Democratic Republic of the Congo: Lessons from Kasai (2025) and emerging challenges from the Bundibugyo resurgence</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-36922-mi025010145-cc4b9789/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-36922-mi025010145-cc4b9789/</guid>
    <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
    <description>By contrasting successful containment tactics with unresolved logistical barriers, the text underscores the importance of adaptable monitoring networks and region-specific medical countermeasures for managing recurring viral threats.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Identification of Contacts With High Rates of Missed and Asymptomatic Infection Following an Outbreak of Ebola Virus Disease: A Seroepidemiological Study in Likati Health Zone, Democratic Republic of the Congo.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag397-1107525d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag397-1107525d/</guid>
    <pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate>
    <description>Undetected infections among both monitored and unmonitored contacts indicate that standard tracking protocols likely miss a significant portion of viral spread. Routine blood screening following outbreaks could clarify transmission networks and improve future response planning.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Bundibugyo virus detection during an Ebola virus disease outbreak in the democratic Republic of the Congo: an urgent call for action.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-01015-4-1e848a43/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-01015-4-1e848a43/</guid>
    <pubDate>Mon, 06 Jul 2026 00:00:00 GMT</pubDate>
    <description>Identifying this viral variant demonstrates the requirement for expanded regional monitoring networks and upgraded laboratory infrastructure. Enhancing these operational capacities remains essential for effective emergency management.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development Accelerates.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-12659-msm-954627-55727a36/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-12659-msm-954627-55727a36/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The discussion emphasizes the operational necessity of deploying medical countermeasures during declared crises, especially when conventional clinical management proves insufficient for lowering death rates.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>It&apos;s not just virology: The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda demands a wider public health response.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-29063-ajrh2026-v30i13-1-3cdaa5c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-29063-ajrh2026-v30i13-1-3cdaa5c3/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The manuscript calls for integrating socioeconomic and environmental interventions into standard outbreak management frameworks to improve long-term resilience.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Closing Critical Gaps in the 2026 Bundibugyo Ebola Response: Five Actionable Priorities.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7759-cureus-111921-46b92e7b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7759-cureus-111921-46b92e7b/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>Outlining rapid, scalable measures deployable through current infrastructure, the discussion highlights how targeted operational shifts may improve immediate outbreak management while strengthening long-term regional readiness.</description>
    <category>Ebola</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Diagnostics</category>
    <category>One Health</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Healthcare-associated transmission and early IPC system vulnerabilities during the 2026 Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13756-026-01779-8-c7594305/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13756-026-01779-8-c7594305/</guid>
    <pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate>
    <description>The authors suggest that immediate deployment of broad infection control protocols upon symptom onset could mitigate risks associated with diagnostic delays in resource-constrained environments.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Strategic Preparedness for the FIFA World Cup 2026 in Response to the Bundibugoy Ebola Outbreak in the Democratic Republic of Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag056-21e54eb9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag056-21e54eb9/</guid>
    <pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate>
    <description>The discussion identifies operational gaps in managing transmissible disease threats during high-density international tourism and sports tournaments.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessment of Risk to the U.S. Population from the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7522e2-ab9bf047/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7522e2-ab9bf047/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The evaluation outlines domestic preparedness thresholds and clarifies resource requirements for managing imported viral hemorrhagic fever scenarios.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-24-2600508-47cbdcf8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-24-2600508-47cbdcf8/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>These findings contextualize cross-border transmission probabilities and may assist in evaluating international health security measures and travel-related screening protocols.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>MVA-BN monkeypox vaccine safety in a clinical trial in the Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01490-0-faf40751/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01490-0-faf40751/</guid>
    <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
    <description>The findings provide additional evidence from an endemic setting that the MVA-BN vaccine, widely deployed for monkeypox prevention, is generally safe and well-tolerated with predominantly mild injection site reactions.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Congo’s conflicts, minerals and microbes: planetary health implications</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022261-eb59d98a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022261-eb59d98a/</guid>
    <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
    <description>The commentary highlights that without parallel investments in disease surveillance and preparedness systems, expanding mineral extraction could accelerate both regional instability and global health threats through potential transboundary pathogen spread, necessitating integrated One Health approaches.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>‘Our problem here is the pig Ebola’: local accounts of epizootics preceding Ebola outbreaks in north-eastern Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-medhum-2025-013586-27ce4306/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-medhum-2025-013586-27ce4306/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>Documenting regional narratives surrounding animal illness provides valuable context for understanding how communities interpret and report emerging health threats.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid3204-250969-b9ff822e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid3204-250969-b9ff822e/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>Substantial viral circulation within agricultural animals indicates persistent environmental maintenance alongside occasional spillover events affecting people. These observations underscore the importance of maintaining systematic monitoring protocols to evaluate ongoing exposure dynamics.</description>
    <category>Hemorrhagic Fever</category>
    <category>Crimean-Congo hemorrhagic fever</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Negligence and global health: the case of the 2018 ebola outbreak in the Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1590-interface-260322-32efaa44/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1590-interface-260322-32efaa44/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>Understanding the political mechanisms that influence emergency classification helps explain disparities in international aid distribution and response scaling during cross-border epidemics.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Assessment of Epidemic Preparedness for Ebola Virus Disease and Hantavirus in the Kokolo Military Health Zone, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The report underscores the necessity for sustained resource allocation, supply chain optimization, and interagency cooperation to preserve outbreak resilience within defense healthcare networks confronting recurring and novel viral hazards.</description>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mpox in Africa: What we know and what is still lacking</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013148-060ab7b4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013148-060ab7b4/</guid>
    <pubDate>Thu, 12 Jun 2025 00:00:00 GMT</pubDate>
    <description>The authors argue Mpox has the potential to disrupt health systems and undermine progress toward the 2030 sustainable development goals, calling for financial and human resource support from countries both within and outside Africa.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The changing epidemiology of human monkeypox—A potential threat? A systematic review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010141-156f368b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010141-156f368b/</guid>
    <pubDate>Fri, 11 Feb 2022 00:00:00 GMT</pubDate>
    <description>The review highlights the global relevance of monkeypox given its spread beyond endemic African settings and suggests that enhanced surveillance is needed to monitor its evolving epidemiology.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>Travel medicine</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>One Health</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Mapping of Ebola virus spillover: Suitability and seasonal variability at the landscape scale</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</guid>
    <pubDate>Mon, 23 Aug 2021 00:00:00 GMT</pubDate>
    <description>The authors frame GIS-MCE suitability maps as an updatable tool to support surveillance and prevention of future Ebola outbreaks as new knowledge becomes available.</description>
    <category>Ebola</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30313-4-26a9403a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30313-4-26a9403a/</guid>
    <pubDate>Tue, 01 Aug 2017 00:00:00 GMT</pubDate>
    <description>Findings informed dose selection for subsequent phase 3 evaluation of the rVSV∆G-ZEBOV-GP candidate, contributing evidence toward a deployable Ebola virus vaccine following the 2014 Zaire Ebola virus outbreak.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-16-30513-8-b018160f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-16-30513-8-b018160f/</guid>
    <pubDate>Wed, 01 Mar 2017 00:00:00 GMT</pubDate>
    <description>The findings provide estimates for prioritising areas for vaccination during yellow fever outbreaks and demonstrate the potential for predictive modelling to guide targeted vaccine allocation, though practical implementation would require consideration of vaccine supply and delivery constraints.</description>
    <category>Yellow fever</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2016-10-059-a11a8ce2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2016-10-059-a11a8ce2/</guid>
    <pubDate>Thu, 01 Dec 2016 00:00:00 GMT</pubDate>
    <description>The findings demonstrate endemic rubella virus transmission in the studied provinces and identify a substantial susceptible population among women of childbearing age, supporting the planned introduction of rubella-containing vaccine before 2020. The analysis guided recommendations for a catch-up campaign targeting children 9 months to 14 years and routine vaccination of women of childbearing age, aligned with World Health Organization guidance.</description>
    <category>Rubella</category>
    <category>Congenital rubella syndrome</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</guid>
    <pubDate>Thu, 28 Apr 2016 00:00:00 GMT</pubDate>
    <description>Development of an effective Ebola vaccine was identified as a priority for controlling future outbreaks following the West African epidemic that caused over 11,000 deaths.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/</guid>
    <pubDate>Tue, 01 Mar 2016 00:00:00 GMT</pubDate>
    <description>The paper is relevant to Ebola vaccine development because it provides early human safety and immune-response data for a candidate vaccine during an outbreak context. It is positioned as evidence to support later-phase efficacy studies rather than as a population-level effectiveness assessment.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-60553-0-d75ff618/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-60553-0-d75ff618/</guid>
    <pubDate>Mon, 01 Jun 2015 00:00:00 GMT</pubDate>
    <description>This is an early clinical evaluation of an Ebola vaccine candidate, so it is relevant to vaccine development and preparedness work. The study addresses a vaccine targeting the 2014 epidemic strain rather than providing outbreak surveillance evidence.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-62385-0-38ad575b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-62385-0-38ad575b/</guid>
    <pubDate>Wed, 01 Apr 2015 00:00:00 GMT</pubDate>
    <description>The paper is relevant to vaccine development for two high-fatality viral diseases and to early clinical evaluation of candidate vaccines in an African setting. It also provides context for later development work on Ebola vaccine antigens.</description>
    <category>Ebola</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2002-130118-e5d287f8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2002-130118-e5d287f8/</guid>
    <pubDate>Sat, 01 Feb 2014 00:00:00 GMT</pubDate>
    <description>The authors call for improved surveillance to monitor potential adaptation of monkeypox virus to humans.</description>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Understanding the dynamics of Ebola epidemics</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268806007217-bbe032f1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268806007217-bbe032f1/</guid>
    <pubDate>Tue, 26 Sep 2006 00:00:00 GMT</pubDate>
    <description>The findings suggest that rapid hospitalization is a key intervention for reducing Ebola epidemic size, providing quantitative support for containment strategies.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>COVID-19</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Ebola haemorrhagic fever in Zaire, 1976.</title>
    <link>https://globalinfectiousdisease.com/research/articles/ebola-haemorrhagic-fever-in-zaire-1976-0ab60c75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/ebola-haemorrhagic-fever-in-zaire-1976-0ab60c75/</guid>
    <pubDate>Sun, 01 Jan 1978 00:00:00 GMT</pubDate>
    <description>A foundational outbreak investigation for Ebola surveillance and response history.</description>
    <category>Ebola</category>
    <category>Viral hemorrhagic fevers</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
  </item>
</channel>
</rss>
